Comments
Loading...
Verona Pharma Insider Trading Activity | NASDAQ:VRNA | Benzinga
Track the latest Verona Pharma insider trading activity. Stay informed on recent buys, sells, and market impact for Verona Pharma stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Verona Pharma PLC Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
- On March 13, 2025, Kathleen A Rickard, the company's CHIEF MEDICAL OFFICER sold 79.26K shares for $8.35 each.
Ownership Statistics for Verona Pharma PLC
Shares Outstanding
85.018M
Insider Shares Owned
42.232M
Insider Percentage Owned
6.21%
Institutional Shares Held
24.963M
Institutional Percentage Held
29.4%
| Mar 13, 2025 | Kathleen A Rickard | CHIEF MEDICAL OFFICER | -79.26K | $8.35 | -$661.94K | SELL | -2.95% | 2.61M | Mar 12 | View |
| Dec 06, 2024 | David Zaccardelli | PRESIDENT AND CEO | -870.67K | $5.01 | -$4.36M | SELL | -5.78% | 14.20M | Dec 04 - Dec 06 | View |
| Dec 06, 2024 | Mark Hahn | CHIEF FINANCIAL OFFICER | -881.96K | $5.01 | -$4.42M | SELL | -6.22% | 13.29M | Dec 04 - Dec 06 | View |
| Dec 02, 2024 | Mark Hahn | CHIEF FINANCIAL OFFICER | -113.24K | $5.01 | -$566.82K | SELL | -0.79% | 14.18M | Nov 27 - Dec 02 | View |
| Dec 02, 2024 | David Zaccardelli | PRESIDENT AND CEO | -125.33K | $5.00 | -$627.23K | SELL | -0.82% | 15.08M | Nov 27 - Dec 02 | View |
| Nov 26, 2024 | Mark Hahn | CHIEF FINANCIAL OFFICER | -2.40K | $5.00 | -$12.00K | SELL | -0.02% | 14.29M | Nov 25 - Nov 26 | View |
| Nov 26, 2024 | David Zaccardelli | PRESIDENT AND CEO | -1.60K | $5.00 | -$8.00K | SELL | -0.01% | 15.20M | Nov 25 | View |
| Nov 26, 2024 | Kathleen A Rickard | CHIEF MEDICAL OFFICER | -240.00K | $4.90 | -$1.18M | SELL | -8.24% | 2.67M | Nov 25 | View |
| Nov 18, 2024 | David R Ebsworth | DIRECTOR | 20.00K | $4.44 | $88.80K | BUY | 2.17% | 940.00K | Nov 18 | View |
| Nov 13, 2024 | David Zaccardelli | PRESIDENT AND CEO | -2.40K | $5.00 | -$12.00K | SELL | -0.02% | 15.20M | Nov 11 | View |
| Nov 13, 2024 | Mark Hahn | CHIEF FINANCIAL OFFICER | -2.40K | $5.00 | -$12.00K | SELL | -0.02% | 14.29M | Nov 11 | View |
| Nov 07, 2024 | David R Ebsworth | DIRECTOR | 39.36K | $4.80 | $188.88K | BUY | 4.47% | 920.00K | Nov 06 | View |
| Nov 07, 2024 | Christina Ackermann | DIRECTOR | 41.88K | $4.74 | $198.39K | BUY | ∞ | 41.88K | Nov 06 | View |
| Nov 05, 2024 | David Zaccardelli | PRESIDENT AND CEO | -141.03K | $4.39 | -$618.66K | SELL | -0.92% | 15.20M | Nov 01 - Nov 04 | View |
| Nov 05, 2024 | Mark Hahn | CHIEF FINANCIAL OFFICER | -129.67K | $4.38 | -$568.39K | SELL | -0.90% | 14.29M | Nov 01 - Nov 04 | View |
| Oct 25, 2024 | Mark Hahn | CHIEF FINANCIAL OFFICER | -144.56K | $4.38 | -$632.76K | SELL | -1.05% | 13.67M | Oct 24 - Oct 25 | View |
| Oct 25, 2024 | David Zaccardelli | PRESIDENT AND CEO | -144.82K | $4.38 | -$633.90K | SELL | -0.98% | 14.59M | Oct 23 - Oct 25 | View |
| Oct 22, 2024 | David Zaccardelli | PRESIDENT AND CEO | -514.15K | $4.38 | -$2.25M | SELL | -3.37% | 14.74M | Oct 18 - Oct 22 | View |
| Oct 22, 2024 | Mark Hahn | CHIEF FINANCIAL OFFICER | -525.77K | $4.38 | -$2.30M | SELL | -3.67% | 13.81M | Oct 18 - Oct 22 | View |
| Sep 13, 2024 | David Zaccardelli | PRESIDENT AND CEO | -600.00K | $3.76 | -$2.25M | SELL | -3.79% | 15.25M | Sep 11 | View |
| Sep 13, 2024 | Mark Hahn | CHIEF FINANCIAL OFFICER | -600.00K | $3.76 | -$2.25M | SELL | -4.02% | 14.34M | Sep 11 | View |
| Aug 14, 2024 | David Zaccardelli | PRESIDENT AND CEO | -400.00K | $3.20 | -$1.28M | SELL | -2.46% | 15.85M | Aug 12 - Aug 13 | View |
| Aug 14, 2024 | Mark Hahn | CHIEF FINANCIAL OFFICER | -400.00K | $3.20 | -$1.28M | SELL | -2.61% | 14.94M | Aug 12 - Aug 13 | View |
| Aug 14, 2024 | David Ebsworth | DIRECTOR | 36.00K | $2.87 | $103.32K | BUY | 4.26% | 880.64K | Aug 12 | View |
| May 03, 2024 | Kathleen A Rickard | CHIEF MEDICAL OFFICER | -110.07K | $1.94 | -$213.61K | SELL | -4.03% | 2.62M | May 01 - May 03 | View |
| Feb 05, 2024 | Kathleen A Rickard | CHIEF MEDICAL OFFICER | -109.02K | $2.27 | -$247.42K | SELL | -3.84% | 2.73M | Feb 01 - Feb 05 | View |
| Nov 22, 2023 | Martin Edwards | DIRECTOR | 33.74K | $1.84 | $61.97K | BUY | 30.38% | 144.80K | Nov 20 | View |
| Nov 08, 2023 | David R Ebsworth | DIRECTOR | 160.00K | $1.98 | $316.08K | BUY | 23.37% | 844.64K | Nov 06 | View |
| Nov 03, 2023 | Kathleen A Rickard | CHIEF MEDICAL OFFICER | -231.89K | $1.79 | -$414.72K | SELL | -7.55% | 2.84M | Nov 01 - Nov 03 | View |
| Aug 07, 2023 | Kathleen A Rickard | CHIEF MEDICAL OFFICER | -80.14K | $2.53 | -$202.58K | SELL | -2.71% | 2.87M | Aug 03 - Aug 07 | View |
| Aug 07, 2023 | David Zaccardelli | PRESIDENT AND CEO | -275.89K | $2.52 | -$693.90K | SELL | -1.65% | 16.43M | Aug 03 - Aug 07 | View |
| Aug 07, 2023 | Mark Hahn | CHIEF FINANCIAL OFFICER | -275.89K | $2.52 | -$693.90K | SELL | -1.75% | 15.52M | Aug 03 - Aug 07 | View |
| Aug 07, 2023 | Claire Poll | GENERAL COUNSEL | -48.47K | $2.52 | -$121.91K | SELL | -5.31% | 864.23K | Aug 03 - Aug 07 | View |
| Aug 03, 2023 | Mark Hahn | CHIEF FINANCIAL OFFICER | -179.65K | $2.64 | -$474.94K | SELL | -1.12% | 15.80M | Aug 01 - Aug 02 | View |
| Aug 03, 2023 | Claire Poll | GENERAL COUNSEL | -31.55K | $2.64 | -$83.41K | SELL | -1.14% | 2.73M | Aug 01 - Aug 02 | View |
| Aug 03, 2023 | David Zaccardelli | PRESIDENT AND CEO | -179.65K | $2.64 | -$474.94K | SELL | -1.06% | 16.71M | Aug 01 - Aug 02 | View |
| Aug 03, 2023 | Kathleen A Rickard | CHIEF MEDICAL OFFICER | -33.46K | $2.64 | -$88.47K | SELL | -1.12% | 2.95M | Aug 01 - Aug 02 | View |
| May 15, 2023 | ORBIMED ADVISORS LLCOrbiMed Capital GP VI LLC | DIRECTOR | -482.91K | $20.58 | -$9.94M | SELL | -11.33% | 3.78M | May 11 - May 15 | View |
| May 15, 2023 | Rishi Gupta | DIRECTOR | -482.91K | $20.58 | -$9.94M | SELL | -11.33% | 3.78M | May 11 - May 15 | View |
| May 03, 2023 | Claire Poll | GENERAL COUNSEL | -80.38K | $2.58 | -$207.04K | SELL | -2.84% | 2.75M | May 01 | View |
| May 03, 2023 | Kathleen A Rickard | CHIEF MEDICAL OFFICER | -106.18K | $2.60 | -$275.68K | SELL | -3.45% | 2.97M | May 01 - May 03 | View |
| May 03, 2023 | Mark Hahn | CHIEF FINANCIAL OFFICER | -455.53K | $2.58 | -$1.17M | SELL | -2.77% | 15.98M | May 01 | View |
| May 03, 2023 | David Zaccardelli | PRESIDENT AND CEO | -455.54K | $2.58 | -$1.17M | SELL | -2.63% | 16.89M | May 01 | View |
| Feb 03, 2023 | Mark Hahn | CHIEF FINANCIAL OFFICER | -413.17K | $2.56 | -$1.06M | SELL | -2.45% | 16.43M | Feb 01 | View |
| Feb 03, 2023 | David Zaccardelli | PRESIDENT AND CEO | -432.93K | $2.56 | -$1.11M | SELL | -2.44% | 17.34M | Feb 01 | View |
| Feb 03, 2023 | Kathleen A Rickard | CHIEF MEDICAL OFFICER | -13.71K | $2.55 | -$302.73K | SELL | -0.44% | 3.08M | Jan 20 - Feb 02 | View |
| Feb 03, 2023 | Claire Poll | GENERAL COUNSEL | 26.80K | $2.59 | -$394.27K | SELL-OPTIONS | 3.59% | 774.26K | Jan 20 - Feb 01 | View |
| Dec 27, 2022 | Claire Poll | GENERAL COUNSEL | -240.00K | $2.69 | -$646.03K | SELL | -23.66% | 774.26K | Nov 21 - Dec 22 | View |
| Dec 27, 2022 | ORBIMED ADVISORS LLCOrbiMed Capital GP VI LLC | DIRECTOR | -6.14M | $22.15 | -$136.00M | SELL | -15.26% | 34.09M | Dec 22 - Dec 23 | View |
| Dec 27, 2022 | Rishi Gupta | DIRECTOR | -6.14M | $22.15 | -$136.00M | SELL | -15.26% | 34.09M | Dec 22 - Dec 23 | View |
| Dec 21, 2022 | David Zaccardelli | PRESIDENT AND CEO | -600.00K | $2.12 | -$1.27M | SELL | -3.27% | 17.78M | Dec 20 | View |
| Dec 21, 2022 | Mark Hahn | CHIEF FINANCIAL OFFICER | -600.00K | $2.12 | -$1.27M | SELL | -3.44% | 16.85M | Dec 20 | View |
| Nov 03, 2022 | David Zaccardelli | PRESIDENT AND CEO | -487.76K | $1.60 | -$782.80K | SELL | -2.59% | 18.38M | Nov 01 | View |
| Nov 03, 2022 | Kathleen A Rickard | CHIEF MEDICAL OFFICER | -85.02K | $1.61 | -$137.15K | SELL | -2.68% | 3.09M | Nov 01 | View |
| Nov 03, 2022 | Mark Hahn | CHIEF FINANCIAL OFFICER | -468.02K | $1.60 | -$749.78K | SELL | -2.61% | 17.45M | Nov 01 | View |
| Aug 17, 2022 | Access Industries Holdings LLCAI Biotechnology LLCACCESS INDUSTRIES MANAGEMENT LLCLen Blavatnik | 10% OWNER | 4.80M | $1.31 | $6.30M | BUY | 9.39% | 55.91M | Aug 15 | View |
| Aug 11, 2022 | David Zaccardelli | PRESIDENT AND CEO | -600.00K | $1.75 | -$1.05M | SELL | -3.78% | 15.26M | Aug 09 | View |
| Aug 11, 2022 | Mark Hahn | CHIEF FINANCIAL OFFICER | -600.00K | $1.75 | -$1.05M | SELL | -4.02% | 14.31M | Aug 09 | View |
| Aug 03, 2022 | David Zaccardelli | PRESIDENT AND CEO | -487.77K | $0.67 | -$328.92K | SELL | -2.98% | 15.86M | Aug 01 | View |
| Aug 03, 2022 | Kathleen A Rickard | CHIEF MEDICAL OFFICER | -85.18K | $0.68 | -$58.17K | SELL | -3.46% | 2.38M | Aug 01 - Aug 02 | View |
| Aug 03, 2022 | Mark Hahn | CHIEF FINANCIAL OFFICER | -468.02K | $0.67 | -$315.11K | SELL | -3.04% | 14.91M | Aug 01 | View |
| May 05, 2022 | David Zaccardelli | PRESIDENT AND CEO | -32.90K | $0.50 | -$16.31K | SELL | -0.20% | 16.35M | May 03 | View |
| May 05, 2022 | Kathleen A Rickard | CHIEF MEDICAL OFFICER | -28.75K | $0.49 | -$14.15K | SELL | -1.15% | 2.46M | May 03 | View |
| May 05, 2022 | Mark Hahn | CHIEF FINANCIAL OFFICER | -12.51K | $0.50 | -$6.20K | SELL | -0.08% | 15.38M | May 03 | View |
| Apr 12, 2022 | Kathleen Rickard | CHIEF MEDICAL OFFICER | -172.52K | $0.57 | -$98.48K | SELL | -6.35% | 2.55M | Apr 08 - Apr 11 | View |
| Feb 03, 2022 | Lisa Deschamps | DIRECTOR | -11.66K | $0.78 | -$9.07K | SELL | -14.23% | 70.32K | Feb 01 | View |
| Feb 03, 2022 | David Zaccardelli | PRESIDENT AND CEO | -6.26K | $0.76 | -$11.85K | SELL | -0.04% | 16.84M | Feb 01 - Feb 03 | View |
| Feb 03, 2022 | Mark Hahn | CHIEF FINANCIAL OFFICER | -164.96K | $0.76 | -$131.67K | SELL | -1.03% | 15.83M | Feb 01 - Feb 02 | View |
| Nov 03, 2021 | Lisa Deschamps | DIRECTOR | -11.67K | $0.66 | -$7.69K | SELL | -12.46% | 81.98K | Nov 02 | View |
| Nov 03, 2021 | David Zaccardelli | PRESIDENT AND CEO | -506.90K | $0.64 | -$324.48K | SELL | -2.92% | 16.85M | Nov 01 - Nov 02 | View |
| Nov 03, 2021 | Mark Hahn | CHIEF FINANCIAL OFFICER | -465.26K | $0.64 | -$297.82K | SELL | -2.83% | 15.99M | Nov 01 - Nov 02 | View |
| Aug 09, 2021 | David Zaccardelli | PRESIDENT AND CEO | -17.66K | $0.75 | -$13.28K | SELL | -0.10% | 17.35M | Aug 03 | View |
| Aug 04, 2021 | David Zaccardelli | PRESIDENT AND CEO | -489.25K | $0.78 | -$382.94K | SELL | -2.74% | 17.37M | Aug 01 - Aug 04 | View |
| Aug 03, 2021 | Mark Hahn | CHIEF FINANCIAL OFFICER | -465.26K | $0.78 | -$365.04K | SELL | -2.75% | 16.46M | Aug 01 - Aug 02 | View |
| May 05, 2021 | Anders Ullman | DIRECTOR | -12.06K | $0.84 | -$10.12K | SELL | -3.48% | 334.86K | May 04 | View |
| May 05, 2021 | Lisa Deschamps | DIRECTOR | -10.68K | $0.84 | -$8.97K | SELL | -9.21% | 105.32K | May 04 | View |
| May 05, 2021 | Kenneth Cunningham | DIRECTOR | -13.11K | $0.84 | -$11.01K | SELL | -16.45% | 66.58K | May 04 | View |
| May 05, 2021 | Vikas Sinha | DIRECTOR | -10.02K | $0.84 | -$8.41K | SELL | -11.86% | 74.44K | May 04 | View |
| May 05, 2021 | David Ebsworth | DIRECTOR | -11.18K | $0.84 | -$9.39K | SELL | -1.61% | 684.64K | May 04 | View |
| May 05, 2021 | Martin Edwards | DIRECTOR | -12.02K | $0.84 | -$10.10K | SELL | -9.77% | 111.06K | May 04 | View |
| May 05, 2021 | Mahendra Shah | DIRECTOR | -10.68K | $0.84 | -$8.97K | SELL | -12.75% | 73.08K | May 04 | View |
| May 05, 2021 | David Zaccardelli | PRESIDENT AND CEO | -2.19M | $0.89 | -$1.94M | SELL | -10.93% | 17.86M | May 03 - May 04 | View |
| May 05, 2021 | Mark Hahn | CHIEF FINANCIAL OFFICER | -2.13M | $0.89 | -$1.89M | SELL | -11.19% | 16.92M | May 03 | View |
| Mar 03, 2021 | Mark Hahn | CHIEF FINANCIAL OFFICER | -26.73K | $1.14 | -$30.57K | SELL | -0.14% | 19.05M | Mar 01 | View |
| Mar 03, 2021 | David Zaccardelli | PRESIDENT AND CEO | -43.39K | $1.14 | -$49.63K | SELL | -0.22% | 20.05M | Mar 01 | View |
| Feb 03, 2021 | Anders Ullman | DIRECTOR | -10.80K | $0.99 | -$10.73K | SELL | -3.02% | 346.91K | Feb 01 | View |
| Feb 03, 2021 | Vikas Sinha | DIRECTOR | -10.22K | $0.99 | -$10.16K | SELL | -10.80% | 84.46K | Feb 01 | View |
| Feb 03, 2021 | Mahendra Shah | DIRECTOR | -10.80K | $0.99 | -$10.73K | SELL | -11.42% | 83.76K | Feb 01 | View |
| Feb 03, 2021 | Martin Edwards | DIRECTOR | -13.69K | $0.99 | -$13.60K | SELL | -10.01% | 123.09K | Feb 01 | View |
| Feb 03, 2021 | David Ebsworth | DIRECTOR | -11.91K | $0.99 | -$11.84K | SELL | -1.68% | 695.83K | Feb 01 | View |
| Feb 03, 2021 | Kenneth Cunningham | DIRECTOR | -13.10K | $0.99 | -$13.02K | SELL | -14.12% | 79.70K | Feb 01 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.